---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-001983"
form_type: "8-K"
ticker: "ORMP"
cik: "0001176309"
company_name: "ORAMED PHARMACEUTICALS INC."
filed_at: "2026-01-07T23:59:59+00:00"
generated_at: "2026-05-16T11:19:24.437514+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Oramed receives $18M payment from Scilex, approves $0.25/share dividend

## Summary
- $18M payment from Scilex closes Option Agreement; current returns total $118M on $99.5M investment.
- Retains $27M note, $12M convertible note ($36/share option), warrants, and nine-year royalty interest.
- Board approves $0.25/share cash dividend; payable Jan 26, 2026 to holders of record Jan 16, 2026.
- Aggregate dividend ~$10.5M, funded from surplus capital.

## SEC filing metadata
- accession: 0001213900-26-001983
- form_type: 8-K
- ticker: ORMP
- cik: 0001176309
- company_name: ORAMED PHARMACEUTICALS INC.
- filed_at: 2026-01-07T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1176309/000121390026001983/0001213900-26-001983-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1176309/000121390026001983/ea0271929-8k_oramed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-001983
- JSON: https://secwatch.observer/filing/0001213900-26-001983.json
- Plain text: https://secwatch.observer/filing/0001213900-26-001983.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.